A Prospective Multicenter Study of Different Surgical Methods in the Treatment of High Myopic Macular Schisis

NCT04146350 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2019-10-31

No results posted yet for this study

Summary

In view of the current problem of treating high myopic macular schisis, the main purpose of our study is to find out the most appropriate time of surgical intervention, to compare the effectiveness and safety of various surgical methods in the treatment of high myopic macular schisis, and to find out the advantages and disadvantages of each surgical method in the treatment of MF. As well as the outcomes and complications of long-term follow-up.

Conditions

  • Macular Schisis

Interventions

PROCEDURE

PPV+/-Cat

pars plana vitrectomy+/-cataract

PROCEDURE

PPV+/-Cat+Gas

pars plana vitrectomy+/-cataract+gas tamponade

PROCEDURE

PPV+ILM+/-Cat+/-Gas

pars plana vitrectomy+internal limiting membrane peeling+/-cataract+/-gas tamponade

PROCEDURE

PPV+ILM+/-Cat+/-Oil

pars plana vitrectomy+internal limiting membrane peeling+/-cataract+/-silicone oil tamponade

PROCEDURE

PSR

posterior scleral reinforcement

PROCEDURE

PSR+ PPV+ILM+/-Cat+/-Oil (or Gas)

posterior scleral reinforcement+pars plana vitrectomy+internal limiting membrane peeling+/-cataract+/-silicone oil tamponade (or gas)

PROCEDURE

Gas

gas tamponade alone

Sponsors & Collaborators

  • Aier School of Ophthalmology, Central South University

    lead OTHER

Principal Investigators

  • Weisheng Li · Shanghai Aier Eye Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-07
Primary Completion
2021-10-07
Completion
2022-06-07

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04146350 on ClinicalTrials.gov